← back to search

Jens‐Erik Beck Jensen

Hvidovre Hospital · DK
Area of research
Orthopedics and Sports Medicine · Oncology
Research interest
Research interests include Bone health and osteoporosis research, Bone health and treatments, Vitamin D Research Studies, and Parathyroid Disorders and Treatments.
h-index
47
citations
11,051
works
283
NIH funding
primary concept
Medicine
email

Recent publications

[Pregnancy- and breastfeeding-associated osteoporosis].
2026cited by 0position: contributordoi
Bilateral healing of pseudofractures in hypophosphatasia with teriparatide: a case report.
2026cited by 0position: contributordoi
Fracture risk and treatment thresholds in patients with diabetes.
2026cited by 0position: contributordoi
[Sequence treatment of postmenopausal osteoporosis].
2025cited by 0position: contributordoi
Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial.
2024cited by 88position: contributordoi
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial.
2023cited by 96position: contributordoi
Primary hyperparathyroidism and fracture probability.
2023cited by 25position: contributordoi
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
2023cited by 7position: contributordoi
No effect of multi-strain probiotic supplementation on metabolic and inflammatory markers and newborn body composition in pregnant women with obesity: Results from a randomized, double-blind placebo-controlled study.
2023cited by 3position: contributordoi
Primary hyperparathyroidism and fracture probability
Osteoporosis International 2022cited by 36position: middledoi
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes.
2022cited by 19position: contributordoi
Frailty and osteoporosis in patients with hip fractures under the age of 60-a prospective cohort of 218 individuals.
2022cited by 16position: contributordoi
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study.
2022cited by 11position: contributordoi
Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
2022cited by 7position: contributordoi
The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study.
2022cited by 6position: contributordoi
Bone-microarchitecture and bone-strength in a sample of adults with hypophosphatasia and a matched reference population assessed by HR-pQCT and impact microindentation.
2022cited by 5position: contributordoi
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
2021cited by 344position: contributordoi
The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypoparathyroidism-A Randomized Crossover Study.
2021cited by 27position: contributordoi
Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; Data from an endocrinological outpatient clinic in Denmark.
2021cited by 12position: contributordoi
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals.
2021cited by 11position: contributordoi
Feasibility and preliminary effect of anabolic steroids in addition to strength training and nutritional supplement in rehabilitation of patients with hip fracture: a randomized controlled pilot trial (HIP-SAP1 trial).
2021cited by 7position: contributordoi
Severe hypocalcemia due to hypoparathyroidism associated with HIV: A case report.
2021cited by 1position: contributordoi
Prevalence of and Risk Factors for Low Bone Mineral Density Assessed by Quantitative Computed Tomography in People Living With HIV and Uninfected Controls.
2020cited by 14position: contributordoi
Outcome of osteoporosis evaluation, treatment, and follow-up in patients referred to a specialized outpatient clinic compared to patients in care of general practitioners.
2020cited by 4position: contributordoi
Newborn body composition after maternal bariatric surgery.
2020cited by 3position: contributordoi
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
2019cited by 126position: contributordoi
Multiple Fractures and Impaired Bone Fracture Healing in a Patient with Pycnodysostosis and Hypophosphatasia.
2019cited by 4position: contributordoi
Intensive screening for osteoporosis in patients with hip fracture.
2019cited by 3position: contributordoi
Preliminary effect and feasibility of physiotherapy with strength training and protein-rich nutritional supplement in combination with anabolic steroids in cross-continuum rehabilitation of patients with hip fracture: protocol for a blinded randomized controlled pilot trial (HIP-SAP1 trial).
2019cited by 2position: contributordoi
[Bilateral atypical femoral fractures after prolonged antiresorptive treatment].
2019cited by 0position: contributor

Grants

No grants ingested yet.

Frequent collaborators

Signe Sørensen Torekov · Novo Nordisk Foundation4 papers (2021–2024)Bente Stallknecht · University of Copenhagen3 papers (2021–2024)Thomas Bandholm · University of Copenhagen3 papers (2019–2021)Ove Törring · Karolinska Institutet2 papers (2012–2017)Jens J. Holst · Capital Region of Denmark2 papers (2023–2024)Niklas R. Jørgensen · Technical University of Denmark2 papers (2019–2022)Kirsten Nørgaard · University of Adelaide2 papers (2020–2022)Kirstine N. Bojsen-Møller · Amager Hospital2 papers (2021–2023) · 2 papers (2022–2023) · 2 papers (2012–2022) · 2 papers (2012–2017)Henrik Kehlet · Aalborg University2 papers (2019–2021)Jacques P. Brown · Université Laval2 papers (2012–2017)Christian Roux · University of Alabama at Birmingham2 papers (2012–2017)Andrea Wang · Amgen (United States)1 papers (2012–2012) · 1 papers (2022–2022)Anne Pernille Hermann · Odense University Hospital1 papers (2022–2022) · 1 papers (2012–2012)Stephen J. Fuller · Nepean Hospital1 papers (2012–2012)Richard Eastell · University of Sheffield1 papers (2017–2017)